In Grade 3 tumors (Figure 2Ad), CLDN8 expression was significantly reduced, exhibiting a homogeneous staining pattern with minimal membrane localization, further indicating the loss of barrier function in high-grade breast cancer. Here, CLDN8 is linked to breast carcinoma.